Stephen Wargacki

Companies

• Aquestive Therapeutics, Inc.SVP, Research & Development Jan 11, 2023 to Mar 11, 2025¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAquestive Therapeutics, Inc. AQST343,552 shares²$1.3M at $3.75Mar 10, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 10, 2025Shares withheld for tax 4,572 shares at $2.54 of Aquestive Therapeutics, Inc.²
• Mar 9, 2025Shares withheld for tax 15,431 shares at $2.65 of Aquestive Therapeutics, Inc.²
• Mar 7, 2025Shares withheld for tax 12,859 shares at $2.65 of Aquestive Therapeutics, Inc.²
• Mar 7, 2025Granted 115,000 shares of Aquestive Therapeutics, Inc.²
• May 10, 2024Granted 10,000 shares of Aquestive Therapeutics, Inc.³
• Mar 10, 2024Shares withheld for tax 1,687 shares at $4.88 of Aquestive Therapeutics, Inc.⁴
• Mar 9, 2024Shares withheld for tax 11,269 shares at $4.88 of Aquestive Therapeutics, Inc.⁴
• Mar 9, 2024Shares withheld for tax 19,505 shares at $4.88 of Aquestive Therapeutics, Inc.⁵
• Mar 7, 2024Granted 112,500 shares of Aquestive Therapeutics, Inc.⁶
• Mar 10, 2023Shares withheld for tax 1,981 shares at $0.79 of Aquestive Therapeutics, Inc.⁶
• Mar 9, 2023Granted 135,000 shares of Aquestive Therapeutics, Inc.⁷